On November 11, 2024, Rosy Lee, Global President of Thermo Fisher Scientific's Genetic Sciences Division (referred to as “Thermo Fisher”), Maggie Zhou, Global Vice President of Finance for the Genetic Sciences Division, and Shuqi Zhuang, Senior Business Director for China in the Genetic Sciences Division, visited Health Gene Tech for a touring visit. Ding Yu, Chairman and CEO of Health Gene Technologies, Dr. Yong Wu, CTO of Health Gene Technologies, Wentao Hu, General Manager of Clinical Diagnostic Division of Health Gene Technologies; and Jerry, Deputy General Manager & Market Director Clinical Diagnostic, welcomed the team. Thermo Fisher chose Health Gene Tech as their first stop on Rosy Lee's China visit, and it underscores the high priority both parties place on innovation and collaboration, as well as their shared commitment to these goals.
The two sides conducted an in-depth introduction and review of their long-term cooperation and jointly looked forward to the future cooperation blueprint. This visit marked a significant milestone in the partnership between the two sides in the fields of precision medicine and scientific research. Over the years, Health Gene Tech and Thermo Fisher have maintained a close cooperative relationship, jointly promoting the application and development of precision medicine and scientific research. The partnership extends beyond business into shared vision and strategic alignment.
During the meeting, Chairman Ding Yu gave a detailed introduction to the operating status of Health Gene Tech and the development of its various business segments, particularly the product pipeline development and strategic roadmap of the capillary electrophoresis (CE) Sanger sequencing platform. He said that Thermo Fisher, as an important driver of global technological progress, has always led the development of global analytical instruments with its strong innovation capabilities and comprehensive management system. Health Gene Tech looks forward to further strengthening cooperation between the two sides in the future to jointly promote the development of the life sciences field.
Rosy Lee, Global President of Thermo Fisher Scientific's Genetic Sciences Division, highly praised the capabilities of Health Gene Tech and stated that Health Gene Tech is a trusted strategic partner of Thermo Fisher. She also highly commended Health Gene Tech's outstanding contributions in capillary electrophoresis (CE) technology. Over the years, Thermo Fisher and Health Gene Tech have maintained close cooperation in their business fields and achieved fruitful results. It is believed that in the future, the cooperation between the two parties will reach new heights.
Currently, China's IVD industry is undergoing rapid development, and Health Gene Tech and Thermo Fisher have engaged in in-depth discussions on future strategic cooperation directions. Both parties aim to leverage innovative technologies to drive industrial upgrading, enhance brand influence, and accelerate market expansion. Additionally, they seek to jointly promote the application and development of molecular technologies in precision medicine and research fields, providing customers with superior products and services, and jointly writing a new chapter of mutually beneficial cooperation.
Looking ahead, we are confident that through our joint efforts, Health Gene Tech and Thermo Fisher will achieve more breakthroughs and achievements in precision medicine and research. Let us work together to create a brighter future!
About HEALTH Gene Technologies
Ningbo HEALTH Gene Technologies Co.,Ltd. (HGT) is a high-tech enterprise specialized in medical laboratory technology and related products R&D, manufacturing, marketing and services.
The main business covers two fields of clinical diagnosis and forensic science. Holding to the corporate mission of “Safer Society, Healthier Life”, HGT, committed to providing comprehensive medical testing application solutions to molecular diagnosis, immunodiagosis, biochemical diagnosis for medical institutions and disease control centers at all levels, and provide complete technical solutions to DNA individual and kinship identification for public security systems and judicial institutions.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue over $40 billion.
Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them.
Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
